1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

Technology appraisal guidance [TA455] Published: 12 July 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 235 KB 12 July 2017  

Final appraisal determination

  • Final appraisal determination  
  • Final appraisal determination document PDF 220 KB 09 June 2017  
  • Committee papers PDF 2.26 MB 09 June 2017  
  • Public committee slides PDF 483 KB 09 June 2017  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 189 KB 17 March 2017  
  • Committee papers PDF 23.7 MB 17 March 2017  
  • Public committee slides PDF 1.41 MB 17 March 2017  

Assessment report sent for information

  • Assessment report PDF 6.03 MB 20 January 2017  

Invitation to participate

  • Final scope PDF 107 KB 27 June 2016  
  • Final matrix PDF 89 KB 27 June 2016  
  • NICE's response to comments on the draft scope and provisional matrix PDF 185 KB 27 June 2016  
  • Equality impact assessment (Scoping) PDF 134 KB 27 June 2016  
  • Final protocol PDF 272 KB 27 June 2016  

Draft scope documents

  • Draft scope (pre-referral) PDF 114 KB 27 November 2015  
  • Provisional matrix (pre-referral) PDF 100 KB 27 November 2015